Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | CYTK | VKTX | ||
| Company | Halozyme Therapeutic | Cytokinetics | Viking Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 45.50 | 51.50 | 51.92 | ||
| High | 45.50 | 51.50 | 51.92 | ||
| Low | 45.50 | 51.50 | 51.92 | ||
| Last | 45.50 | 51.50 | 51.92 | ||
| Change | -0.26 | +1.64 | +0.39 | ||
| % Change | -0.57% | +3.29% | +0.76% | ||
| Volume | 996 | 1,204 | 28,038 | ||
| 20-Day Average Volume | 2,045,970 | 1,236,765 | 6,350,477 | ||
| Previous Close | 45.76 | 49.86 | 51.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.23 | 53.13 | 62.99 | ||
| 20-Day Raw Stochastic | 17.35% | 19.08% | 12.53% | ||
| 20-Day Relative Strength | 37.12% | 45.38% | 39.34% | ||
| Weighted Alpha | +12.89 | -10.35 | +32.94 | ||
| Today's Opinion | 40% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 40% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 8% Buy | 80% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.68% since 11/14/24 | -5.85% since 11/14/24 | -3.08% since 11/14/24 | ||
| Low | 42.01 on 11/18/24 | 49.64 on 11/18/24 | 47.65 on 11/18/24 | ||
| High | 49.64 on 11/15/24 | 55.14 on 11/15/24 | 53.20 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -12.11% since 10/21/24 | -4.29% since 10/21/24 | -19.30% since 10/21/24 | ||
| Low | 42.01 on 11/18/24 | 49.64 on 11/18/24 | 47.65 on 11/18/24 | ||
| High | 62.13 on 11/11/24 | 59.39 on 11/11/24 | 81.73 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | -26.81% since 08/21/24 | -8.98% since 08/21/24 | -19.83% since 08/21/24 | ||
| Low | 42.01 on 11/18/24 | 49.64 on 11/18/24 | 47.65 on 11/18/24 | ||
| High | 65.53 on 08/29/24 | 59.39 on 11/11/24 | 81.73 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | -0.09% since 05/21/24 | -14.37% since 05/21/24 | -19.17% since 05/21/24 | ||
| Low | 42.01 on 11/18/24 | 46.25 on 05/28/24 | 46.11 on 06/26/24 | ||
| High | 65.53 on 08/29/24 | 61.38 on 07/26/24 | 81.73 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,821,907 | 5,884,178 | 5,742,296 | ||
| Shares Outstanding, K | 127,227 | 118,014 | 111,436 | ||
| Annual Sales | 829,250,000 | 7,530,000 | 0 | ||
| Annual Net Income | 281,590,000 | -526,240,000 | -85,900,000 | ||
| Last Quarter Sales | 290,080,000 | 460,000 | 0 | ||
| Last Quarter Net Income | 137,010,000 | -160,550,000 | -24,940,000 | ||
| 60-Month Beta | 1.29 | 0.78 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.27 on 10/31/24 | -1.36 on 11/06/24 | -0.22 on 10/23/24 | ||
| Latest Earnings Date | 10/31/24 | 11/06/24 | 10/23/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 12.88 | 0.00 | 0.00 | ||